Comparative Efficacy and Safety of Oral P2Y(12) Inhibitors in Acute Coronary Syndrome: Network Meta-Analysis of 52 816 Patients From 12 Randomized Trials

BACKGROUND: New randomized, controlled trials have become available on oral P2Y(12) inhibitors in acute coronary syndrome. We aimed to evaluate current evidence comparing the efficacy and safety profile of prasugrel, ticagrelor, and clopidogrel in acute coronary syndrome by a meta-analysis of random...

Full description

Saved in:
Bibliographic Details
Published in:Circulation
Main Authors: Navarese, Eliano P., Khan, Safi U., Kołodziejczak, Michalina, Kubica, Jacek, Buccheri, Sergio, Cannon, Christopher P., Gurbel, Paul A., De Servi, Stefano, Budaj, Andrzej, Bartorelli, Antonio, Trabattoni, Daniela, Ohman, E. Magnus, Wallentin, Lars, Roe, Matthew T., James, Stefan
Format: Artigo
Language:Inglês
Published: 2020
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7489363/
https://ncbi.nlm.nih.gov/pubmed/32468837
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCULATIONAHA.120.046786
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items